Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer

British Journal of Surgery

Volumn 94, Issue 12, 2007, Pages 1509-1514

  Morgan, M A ^a   Lewis, W G ^a,b   Crosby, T D L ^c   Escofet, X ^a   Roberts, S A ^a   Brewster, A E ^c   Harvard, T J ^d   Clark, G W B ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

^d ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COHORT STUDIES; EPIRUBICIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 37249090361     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5671     Document Type: Article

References (18)

1. Walsh N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467.
2. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167.
3. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-313.
4. Burmeister BH, Smithers MB, Gebski V, Fitzgerald L, Simes RJ, Devitt P et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668.
5. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733.
6. Mukherjee S, Abraham J, Brewster A, Hardwick R, Havard T, Lewis W et al. Pilot study of preoperative combined modality treatment for locally advanced operable oesophageal carcinoma: toxicities and long-term outcome. Clin Oncol 2006; 18: 338-344.
7. National Cancer Institute. Common terminology criteria for adverse events. http://ctep.cancer.gov/forms/CTCAEv3.pdf [9 August 2006].
8. Kennedy BJ. The unified international gastric cancer staging classification. Scand J Gastroenterol 1987; 22(Suppl 133): 11-13.
9. Sobin LH, Wittekind C (eds). UICC. TNM Classification of Malignant Tumours (5th edn). Wiley-Liss: New York, 1997.
10. Lewis I. The surgical treatment of carcinoma of the Oesophagus, with special reference to a new operation for growths of middle third. Br J Surg 1946; 34: 18-31.
11. Tanner IC. The present position of carcinoma of the oesophagus. Postgrad Med J 1947; 23: 109-139.
12. Orringer MB. Transhiatal oesophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1984; 200: 282-288.
13. Altman DG. Practical Statistics for Medical Research. Chapman and Hall: London, 1991.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 58: 457-481.
15. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-1984.
16. Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002; 183: 274-279.
17. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-543.
18. Stephens MR, Lewis WG, Brewster AE, Lord I, Blackshaw G, Hodzovic I et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus 2006; 19: 164-171.